Cargando…

Identification of a New Prediction Model for Bladder Cancer Related to Immune Functions and Chemotherapy Using Gene Sets of Biological Processes

BACKGROUND: Biological processes serve crucial functions in the initiation and development of cancer. Therefore, we constructed and validated a model for bladder cancer (BLCA) with good predictive power for immunity, prognosis, and therapy. METHODS: Using the expression of the gene sets based on bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huidong, Huang, Guo, Chen, Tao, Zhang, Jianglei, Ouyang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637466/ https://www.ncbi.nlm.nih.gov/pubmed/36349315 http://dx.doi.org/10.1155/2022/4740686

Ejemplares similares

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
por: Zhiyu, Zhang, et al.
Publicado: (2021)

Identification of a Topological Characteristic Responsible for the Biological Robustness of Regulatory Networks
por: Wu, Yangle, et al.
Publicado: (2009)

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
por: Tang, Chaozhi, et al.
Publicado: (2020)

Identification of immune-related and autophagy-related genes for the prediction of survival in bladder cancer
por: Zhu, Quanfeng, et al.
Publicado: (2022)

Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database
por: Guo, Liqiang, et al.
Publicado: (2021)

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
por: Zhou, Guanwen, et al.
Publicado: (2023)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes
por: Wang, Linhui, et al.
Publicado: (2021)

Identification of bladder cancer subtypes and predictive model for prognosis, immune features, and immunotherapy based on neutrophil extracellular trap-related genes
por: Guo, Changhong, et al.
Publicado: (2023)

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
por: Sherif, Amir, et al.
Publicado: (2018)

Identification of immune-related genes as prognostic factors in bladder cancer
por: Zhu, Jie, et al.
Publicado: (2020)

Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer
por: Galsky, Matthew D, et al.
Publicado: (2015)

Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer
por: Ren, Wenjing, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

Identification of differentially expressed genes and biological pathways in bladder cancer
por: Tang, Fucai, et al.
Publicado: (2018)

Identification of key candidate genes and biological pathways in bladder cancer
por: Gao, Xin, et al.
Publicado: (2018)

Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer
por: Zhao, Jiahui, et al.
Publicado: (2022)

Isolation, Identification, and Biological Activity Analysis of Swim Bladder Polypeptides from Acipenser schrencki
por: Zu, Xiao-Yan, et al.
Publicado: (2023)

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)

Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis
por: Kang, Zhen, et al.
Publicado: (2021)

The role of m(6)A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse
por: Zhang, Zhi-Wei, et al.
Publicado: (2023)

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer
por: Yan, Yilin, et al.
Publicado: (2020)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer
por: Wu, Tielin, et al.
Publicado: (2022)

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Miyagi, Hiroko, et al.
Publicado: (2022)

Identification of Immune-Related Breast Cancer Chemotherapy Resistance Genes via Bioinformatics Approaches
por: Du, Yabing, et al.
Publicado: (2022)

Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis
por: Na, Lei, et al.
Publicado: (2020)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
por: Huang, Mengjia, et al.
Publicado: (2021)

A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
por: Guo, Yupeng, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade
por: Luo, Hao, et al.
Publicado: (2022)

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)
por: Xing, Qianwei, et al.
Publicado: (2020)

Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer
por: Dai, Shuang, et al.
Publicado: (2021)

Application of synthetic biology in bladder cancer
por: Ding, Mengting, et al.
Publicado: (2022)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC
por: Chen, Meng-Yu, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
por: Chen, Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rehmutd4nkv9g6jjbd1lt47kc